Flaxseed and lowfat diet slows growth of some prostate cancers - study
DURHAM, N.C /New York, PSA Rising/ July 12, 2001 -- A low-fat diet supplemented with flaxseed
may help reduce the risk of prostate cancer, researchers
from Duke University Medical Center report in the July
issue of Urology.
Dietary fat and fiber can affect
hormone levels and may influence cancer progression, the researchers said.
Flaxseed is high in fiber and is the richest source of
plant-based, omega-3 fatty acids. Studies suggest that
dietary fiber reduces cancer risk, and omega-3 fatty
acids also have shown a protective benefit against
cancer. Flaxseed is also a rich source of lignan, a
specific family of fiber-related compounds that appear to
play a key role in influencing both estrogen and androgen
metabolism.
"We thought flaxseed would be the perfect food for
prostate cancer patients," said lead author Wendy
Demark-Wahnefried, associate research professor in the
department of surgery at Duke. "It's full of omega-3
fatty acids, fiber and lignan. Testosterone may be
important in the progression of prostate cancer, and
lignan in the flaxseed binds testosterone, so we thought
the flaxseed might suppress the growth of prostate cancer
cells. By pairing a low-fat diet with the flaxseed
supplement, we also thought we could maximize the effect
of the omega-3 fatty acids, since studies in animals show
that the kind of fat we eat may be important for cancer
progression."
The pilot study involved 25 patients with prostate cancer
who were awaiting prostatectomy (surgical removal of the
prostate). Baseline levels of prostate-specific antigen
(PSA), testosterone, free androgen index and total serum
cholesterol were determined at the beginning of the
study. The tumors of those on the diet were then matched
with 25 historic cases, equal in age, race, PSA level at
diagnosis and biopsy Gleason sum (a scoring system used
to grade prostate tumors) to compare tumor progression
and biomarkers after the dietary intervention.
The men were on the low-fat, flaxseed-supplemented diet
for an average of 34 days. Finely ground flaxseed was
used in the study because, in its natural form, flaxseed
is a pointy, tough seed that can puncture the intestines
when consumed in the amounts used in this study (three
rounded tablespoons a day). The ground flaxseed in the
study was vacuum-packed (ground flaxseed can quickly go
rancid) and had added emulsifiers for ease of mixing. The
men were instructed to sprinkle the flaxseed on their
cereal or mix it into juices, yogurt or applesauce.
Researchers reported good compliance with the diet and
said it was tolerated well.
At the end of the study, the researchers observed that
the men on the diet had significant decreases in
cholesterol, and both total and free testosterone. While
there was a decrease in testosterone levels, they noted
that none of the participants in the study suffered
decreased libido or sexual dysfunction. There was a trend
toward a decrease in PSA levels in men with early-stage
prostate cancer (Gleason sums of six or less), but in men
with advanced prostate cancer (Gleason sums of more than
six) PSA levels continued to rise.
"It's not surprising that a diet therapy that was
only taken for an average of 34 days had little effect on
men with aggressive disease," Demark-Wahnefried
said. "But what we did see was that for the men on
the diet, their tumor cells did not divide as quickly and
there was a greater rate of apoptosis (tumor cell death)
in this group."
With such a short-term change in diet, the
researchers said they did not expect to see a difference
in tumor biology between the diet-treated patients and
the control patients, but were encouraged by the lower
proliferation rates and significantly higher rates of
apoptotic cell death. However, they said the results
should be interpreted with caution, stressing that
randomized controlled clinical trials are needed to
confirm the results of the pilot study. Research on mice
models is currently under way, and preliminary results
support the findings in humans.
It is still unknown, Demark-Wahnefried said, if the low fat
diet or the flaxseed--or a combination of the two--is the
active component in the tumor reductions. More
studies examining these elements independently are
needed, she added.